Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAESAR: Clinical efficacy study of Pentalong on Pulmonary Hypertension in Heart Failure
DRKS00000629Phase 2Recruiting
- Sponsor
- Allergan
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of isosorbide mononitrate in heart failure (HF) and secondary pulmonary hypertension (2 arms), sponsored by Allergan. Started Jan 2011; status: recruiting.
02
Drugs
isosorbide mononitrate
03
Conditions
heart failure (HF)secondary pulmonary hypertension
Beyond the preview
Go deeper on DRKS00000629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000629.